Allspring Global Investments Holdings LLC Lowers Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Allspring Global Investments Holdings LLC trimmed its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 97.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,325 shares of the company’s stock after selling 1,207,010 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Option Care Health were worth $949,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in OPCH. Blue Trust Inc. grew its stake in Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares during the period. GAMMA Investing LLC lifted its holdings in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares in the last quarter. Trust Point Inc. raised its position in shares of Option Care Health by 2.6% in the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock valued at $755,000 after buying an additional 622 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in Option Care Health by 5.4% during the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock worth $376,000 after acquiring an additional 690 shares during the last quarter. Finally, UMB Bank n.a. lifted its stake in Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Wall Street Analyst Weigh In

OPCH has been the subject of several analyst reports. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the company from $43.00 to $29.00 in a report on Wednesday. Barrington Research cut their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday. JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a report on Thursday.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $23.04 on Friday. The company’s fifty day moving average price is $30.65 and its 200 day moving average price is $29.97. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.76 and a quick ratio of 1.36. Option Care Health, Inc. has a 12 month low of $22.84 and a 12 month high of $34.63. The firm has a market capitalization of $3.94 billion, a P/E ratio of 19.36, a P/E/G ratio of 2.31 and a beta of 1.29.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.22 billion. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.